Aledade appointed Daren Thayne as chief technology officer and Josh C. Mandel, MD, as chief scientist. The announcements are management/technology leadership updates with no disclosed financial guidance, so near-term market impact is likely limited.
Aledade appointed Daren Thayne as chief technology officer and Josh C. Mandel, MD, as chief scientist. The announcements are management/technology leadership updates with no disclosed financial guidance, so near-term market impact is likely limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.08